FBRX Stock Analysis: Buy, Sell, or Hold?
FBRX - Forte Biosciences, Inc. Common Stock
$76.56
-0.05 (-0.07%)
βΌ
5d:
-0.12%
30d:
+275.11%
90d:
+168.54%
WAIT
LOW Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 13, 2026
7d
Get Alerted When FBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: FBRX is 23.0% above its trading range ($62.26). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: FBRX is 23.0% above its trading range ($62.26). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: FBRX is currently trading at $76.56, which is considered extended relative to its 30-day fair value range of $20.58 to $62.26.
Technical Outlook: Technically, FBRX is in a uptrend. The price is approaching resistance at $77.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBRX is in a uptrend. The price is approaching resistance at $77.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.58 -
$62.26
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+23.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($73.80)
- WARNING: Recommendation downgraded due to 23.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$20.58 -
$62.26
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$48.57
Resistance Level
$77.20
Current Trend
Uptrend
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.96
Wall Street Target
$73.80
(-3.6%)
Share & Embed Analysis
Last updated: August 04, 2026 11:14 PM ET
Data refreshes hourly during market hours. Next update: 12:14 AM
Data refreshes hourly during market hours. Next update: 12:14 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals β¦ |
STRONG BUY
30 analysts |
$386 | 42 HOLD |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$557 | 48 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals β¦ |
BUY
22 analysts |
$41 | 59 HOLD |